Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy immunogenicity

A Goldin, A Nicolin, E Bonmassar

    Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The aetiology of the non-ossifying fibroma of the distal femur and its relationship to the surrounding soft tissues.

    Journal of children's orthopaedics·2017
    Same author

    The Concise Guide to PHARMACOLOGY 2013/14: overview.

    British journal of pharmacology·2014
    Same author

    Frequency selective bolometers.

    Applied optics·2010
    Same author

    Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor.

    Nature·2010
    Same author

    Metabolic effects of a nitrogen mustard on mouse sarcoma 180.

    Federation proceedings·2010
    Same author

    On the neurological effect of some chlorinated tertiary amines.

    Federation proceedings·2010
    Same journal

    Future Challenges of Molecular Imaging in Oncology.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    Same journal

    Clinical Applications of Theranostics.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    Same journal

    Internal Radiation Therapy.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    Same journal

    The Role of Molecular Imaging in Ion Beam Therapy.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    Same journal

    Molecular Imaging in Photon Radiotherapy.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    Same journal

    Advancements in Intraoperative Imaging for Enhanced Surgical Precision.

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
    See all related articles

    Combining chemotherapy with immunotherapy, using altered tumor cells or immune cells, significantly enhanced anti-cancer responses in preclinical models. This chemoimmunotherapy approach shows promise for future human cancer treatments.

    Area of Science:

    • Oncology
    • Immunology
    • Cancer Research

    Background:

    • Chemotherapy effectiveness can be limited by tumor resistance.
    • Evidence suggests that a moderate immune response can enhance chemotherapy outcomes.
    • Novel therapeutic strategies are needed to improve cancer treatment efficacy.

    Purpose of the Study:

    • To investigate the efficacy of chemoimmunotherapy combining chemotherapy with modified tumor cells or immune cells.
    • To evaluate the therapeutic potential of antigenically altered tumor cells and specific lymphocytes in cancer treatment.
    • To explore novel combination treatment modalities for enhanced anti-cancer effects.

    Main Methods:

    • Utilizing viable, antigenically altered L1210 cells (L1210/DTCI) for chemoimmunotherapy.

    Related Experiment Videos

  • Administering chemotherapy (BCNU or cyclophosphamide) alongside specific lymphocytes.
  • Treating parental leukemias (L1210 Ha and L1210 Cr) with combined therapeutic approaches.

    • Main Results:

    • Marked therapeutic responses observed in leukemic models treated with chemoimmunotherapy.
    • Combination of chemotherapy with viable L1210/DTCI cells demonstrated significant efficacy.
    • Treatment with chemotherapy and lymphocytes immunized against L1210/DTCI also yielded positive results.

    Conclusions:

    • Chemoimmunotherapy combining chemotherapy with modified tumor cells or immune cells shows significant therapeutic potential.
    • These combined modalities warrant further investigation for treating human cancers.
    • The findings support the exploration of immune-mediated enhancement of chemotherapy.